Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

• Alexander, D. & Leung, P. (2011). The DSM Guided Cannabis Screen (DSM-G-CS): Description, reliability, factor structure and empirical scoring with a clinical sample. Addictive Behaviors 36, 1095-1100.
• Cassidy, C.M., Joober, R., King, S., & Malla, A.K. (2011). Childhood symptoms of inattention-hyperactivity predict cannabis use in first episode psychosis. Schizophrenia Research 132, 171-176.
• Compton, M.T., Simmons, C.M., Weiss, P.S., & West, J.C. (2011). Axis IV Psychosocial problems among patients with psychotic or mood disorders with a cannabis use disorder comorbidity. American Journal on Addictions 20, 563-567.
• Daza-Losada, M., Miñarro, J., Aguilar, M.A., Valverde, O., & Rodríguez-Arias, M. (2011). Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference. Pharmacology, Biochemistry and Behavior 100, 33-39.
• Fouad, A.A. & Jresat, I. (2011). Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats. European Journal of Pharmacology 670, 216-223.
• Gillespie, N.A., Kendler, K.S. & Neale, M.C. (2011). Psychometric modeling of cannabis initiation and use and the symptoms of cannabis abuse, dependence and withdrawal in a sample of male and female twins. Drug and Alcohol Dependence 118, 166-172.
• Guillem, E., Notides, C., Vorspan, F., Debray, M., Nieto, I., Leroux, M., & Lépine, J.P. (2011). Cannabis expectancies in substance misusers: French validation of the marijuana effect expectancy questionnaire. American Journal on Addictions 20, 543-554.
• Houston, J.E., Murphy, J., Shevlin, M., & Adamson, G. (2011). Cannabis use and psychosis: Re-visiting the role of childhood trauma. Psychological Medicine 41, 2339-2348.
• Huestis, M.A. & Mazzoni, I. & Rabin, O. (2011). Cannabis in sport: Anti-doping perspective. Sports Medicine 41, 949-966.
• Lynch, M.E. & Campbell, F. (2011). Cannabinoids for treatment of chronic non-cancer pain; A systematic review of randomized trials. British Journal of Clinical Pharmacology 72, 735-744.
• Maccoun, R.J. (2011). What can we learn from the Dutch cannabis coffeeshop system? Addiction 106, 1899-1910.
• Marroun, H.E., Hudziak, J.J., Tiemeier, H., Creemers, H., Steegers, E.A., Jaddoe, V.W., Hofman, A., Verhulst, F.C., van den Brink, W., & Huizink, A.C. (2011). Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug and Alcohol Dependence 118, 470-474.
• Mayet, A., Legleye, S., Chau, N., & Falissard, B. (2011). Transitions between tobacco and cannabis use among adolescents: A multi-state modeling of progression from onset to daily use. Addictive Behaviors 36, 1101-1105.
• Peters, E.N., Nich, C. & Carroll, K.M. (2011). Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders. Drug and Alcohol Dependence 118, 408-416.
• Schmid, S.M., Lapaire, O., Huang, D.J., Jürgens, F.E., & Güth, U. (2011). Cannabinoid hyperemesis syndrome: An underreported entity causing nausea and vomiting of pregnancy. Archives of Gynecology and Obstetrics 284, 1095-1097.
• Solowij, N., Yücel, M., Respondek, C., Whittle, S., Lindsay, E., Pantelis, C., & Lubman, D.I. (2011). Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychological Medicine 41, 2349-2359.
• van Winkel, R., van Beveren, N.J., Simons, C., the Genetic Risk and Outcome of Psychosis (GROUP) Investigators, Kahn, R.S., Linszen, D.H., van Os, J., Wiersma, D., Bruggeman, R., Cahn, W., de Haan, L., Krabbendam, L., & Myin-Germeys, I. (2011). AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder. Neuropsychopharmacology 36, 2529-2537.
• Zvolensky, M.J., Cougle, J.R., Bonn-Miller, M.O., Norberg, M.M., Johnson, K., Kosiba, J., & Asmundson, G.J. (2011). Chronic pain and marijuana use among a nationally representative sample of adults. American Journal on Addictions 20, 538-542.